{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:52:31Z","timestamp":1761173551130,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.purol.2015.08.007","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T22:06:37Z","timestamp":1443737197000},"page":"1125-1131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["What risk of prostate cancer led urologist to recommend prostate biopsies?"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Roumigui\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-B.","family":"Beauval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bordier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Filleron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Rozet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mottet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Cussenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Malavaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.purol.2015.08.007_bib0145","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S1166-7087(10)70041-5","article-title":"Projected incidence and mortality from urologic cancer in France in 2010","volume":"20","author":"Rebillard","year":"2010","journal-title":"Prog Urol"},{"issue":"6","key":"10.1016\/j.purol.2015.08.007_bib0150","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1166-7087(07)74785-1","article-title":"Prostatic cancers","volume":"17","author":"Soulie","year":"2007","journal-title":"Prog Urol"},{"issue":"Suppl. 4","key":"10.1016\/j.purol.2015.08.007_bib0155","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/S1166-7087(10)70042-7","article-title":"Recommendations Onco-Urology 2010: prostate cancer","volume":"20","author":"Salomon","year":"2010","journal-title":"Prog Urol"},{"issue":"22","key":"10.1016\/j.purol.2015.08.007_bib0160","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level<or =4.0ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.purol.2015.08.007_bib0165","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1852::AID-CNCR25>3.0.CO;2-3","article-title":"The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience","volume":"80","author":"Smith","year":"1997","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.purol.2015.08.007_bib0170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ejca.2004.12.029","article-title":"Screening for prostate cancer","volume":"41","author":"Postma","year":"2005","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.purol.2015.08.007_bib0175","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/pros.22470","article-title":"A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy","volume":"72","author":"Ouzaid","year":"2012","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.purol.2015.08.007_bib0180","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1464-410X.2010.09727.x","article-title":"Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction","volume":"107","author":"Oliveira","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.purol.2015.08.007_bib0185","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.purol.2012.12.007","article-title":"The management of prostate cancer: a retrospective chart review in 808 French men undergoing biopsy","volume":"23","author":"Cussenot","year":"2013","journal-title":"Prog Urol"},{"issue":"8","key":"10.1016\/j.purol.2015.08.007_bib0190","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.purol.2015.08.007_bib0195","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.juro.2010.09.101","article-title":"The prostate cancer risk calculator from the Prostate Cancer Prevention Trial underestimates the risk of high grade cancer in contemporary referral patients","volume":"185","author":"Ngo","year":"2011","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.purol.2015.08.007_bib0200","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/pros.20454","article-title":"The use of nomograms in the detection of prostate cancer","volume":"66","author":"Roobol","year":"2006","journal-title":"Prostate"},{"issue":"15","key":"10.1016\/j.purol.2015.08.007_bib0205","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/pros.20840","article-title":"A graphical device to represent the outcomes of a logistic regression analysis","volume":"68","author":"Kranse","year":"2008","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.purol.2015.08.007_bib0210","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1200\/JCO.2010.31.2330","article-title":"Impact of comorbidity on survival among men with localized prostate cancer","volume":"29","author":"Albertsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2015.08.007_bib0215","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2012.11607.x","article-title":"Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial","author":"Ploussard","year":"2013","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.purol.2015.08.007_bib0220","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2008.20.3422","article-title":"Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach","volume":"28","author":"Gann","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.purol.2015.08.007_bib0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","article-title":"A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer","volume":"57","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2015.08.007_bib0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0272989X07312725","article-title":"Decision curve analysis: a discussion","volume":"28","author":"Steyerberg","year":"2008","journal-title":"Med Decis Making"},{"issue":"12","key":"10.1016\/j.purol.2015.08.007_bib0235","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ejca.2012.02.002","article-title":"Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort","volume":"48","author":"Van Vugt","year":"2012","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.purol.2015.08.007_bib0240","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2008.05.022","article-title":"The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review","volume":"54","author":"Schroder","year":"2008","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2015.08.007_bib0245","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1464-410X.2008.08127.x","article-title":"Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone","volume":"103","author":"Hernandez","year":"2009","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.purol.2015.08.007_bib0250","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.urology.2006.10.022","article-title":"External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population","volume":"68","author":"Parekh","year":"2006","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2015.08.007_bib0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1464-410X.2009.08793.x","article-title":"Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population","volume":"105","author":"Kaplan","year":"2010","journal-title":"BJU Int"},{"issue":"8 Pt 2","key":"10.1016\/j.purol.2015.08.007_bib0260","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1111\/j.1464-410X.2011.10207.x","article-title":"Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort","volume":"108","author":"Trottier","year":"2011","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.purol.2015.08.007_bib0265","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2010.06.023","article-title":"Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer Risk Calculators: a performance comparison in a contemporary screened cohort","volume":"58","author":"Cavadas","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.08.007_bib0270","article-title":"Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy","author":"Ploussard","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2015.08.007_bib0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2010.09.036","article-title":"Prostate cancer detection in the \u201cgrey area\u201d of prostate-specific antigen below 10ng\/mL: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3","volume":"59","author":"Perdona","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2015.08.007_bib0280","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.eururo.2012.07.029","article-title":"A calculator for prostate cancer risk 4 years after an initially negative screen: findings from ERSPC Rotterdam","volume":"63","author":"Roobol","year":"2013","journal-title":"Eur Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708715002420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708715002420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:26:52Z","timestamp":1761114412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708715002420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1166708715002420"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2015.08.007","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What risk of prostate cancer led urologist to recommend prostate biopsies?","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2015.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}